Microbio Co.,LTD. receives a U.S. patent on the new drug MS-20 (CHEMO YOUNG)

SEQ_NO	1	Date of announcement	2021/03/10	Time of announcement	16:45:06
Subject	Microbio Co.,LTD. receives a U.S. patent on the new drug MS-20 (CHEMO YOUNG).
Date of events	2021/03/10	To which item it meets	paragraph 53
Statement	1.Date of occurrence of the event:2021/03/10 2.Company name:Microbio Co.,LTD. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:NA 5.Cause of occurrence:The Company has been informed by the patent agency that the new drug: MS-20 has been granted a U.S. patent titled ”COMBINED CANCER THERAPY WITH IMMUNE CHECKPOINT MODULATORS AND FERMENTATION PRODUCTS BY SYMBIOTIC MICROBIOTA” under patent number US 10,869,923 B2. 6.Countermeasures:NA 7.Any other matters that need to be specified:The new drug MS-20 has obtained patents from the U.S., the Republic of China, Japan, the People’s Republic of China, the Hong Kong Special Administrative Region, Europe, Korea, Indonesia, India, Canada, Malaysia and United Arab Emirates.